Glucose-6-phosphate dehydrogenase deficiency near-patient tests for tafenoquine or primaquine use in malaria treatment and prophylaxis
Report considered by the WHO/GMP Guideline Development Group on Malaria Diagnostics on near-patient G6PD tests to support radical cure of P. vivax and P. ovale for “Section 5.2.1.6 Testing for glucose-6-phosphate dehydrogenase (G6PD) deficiency" of the WHO guidelines for malaria, 30 November 2024.
Institutions
- Patan Academy of Health Sciences (NP)
- Liverpool School of Tropical Medicine (GB)
- Stellenbosch University (ZA)
- Gloucestershire Hospitals NHS Foundation Trust (GB)
- Kenya Medical Research Institute (KE)
- University of Oxford (GB)
- Tribhuvan University Teaching Hospital (NP)
- Mahidol Oxford Tropical Medicine Research Unit (TH)
- Oxford University Hospitals NHS Trust (GB)
- University of Birmingham (GB)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2024-11-29
- DOI
- https://doi.org/10.5281/zenodo.14181675
- Primary Topic
- Malaria Research and Control
- Type
- article
- Field-Weighted Citation Impact
- 0.00